Ben Tre Pharmaceutical JSC (STC:DBT) FCF Margin %: 0.00% (As of . 20)


STC:DBT Ben Tre Pharmaceutical JSC STC:DBT
13 GF Score
Price ₫12,000.00
! 1 Warning Sign
View Full Analysis

What is Ben Tre Pharmaceutical JSC FCF Margin %?

Ben Tre Pharmaceutical JSC STC:DBT -6.25% 13 FCF Margin % is 0.00% as of . 20. GuruFocus rates STC:DBT with a GF Score™ of 13/100. The stock has 1 warning sign investors should review. Among 955 Drug Manufacturers companies, Ben Tre Pharmaceutical JSC ranks worse than 104711.94% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ben Tre Pharmaceutical JSC's Free Cash Flow for the six months ended in . 20 was ₫0.00 Mil. Ben Tre Pharmaceutical JSC's Revenue for the six months ended in . 20 was ₫0.00 Mil. Therefore, Ben Tre Pharmaceutical JSC's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Ben Tre Pharmaceutical JSC's current FCF Yield % is 0.00%.

The historical rank and industry rank for Ben Tre Pharmaceutical JSC's FCF Margin % or its related term are showing as below:


STC:DBT's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.51
* Ranked among companies with meaningful FCF Margin % only.

Ben Tre Pharmaceutical JSC FCF Margin % Related Terms

Ben Tre Pharmaceutical JSC FCF Margin % Historical Data

* Premium members only.

The historical data trend for Ben Tre Pharmaceutical JSC's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ben Tre Pharmaceutical JSC FCF Margin % Chart

Ben Tre Pharmaceutical JSC Annual Data
Trend
FCF Margin %

Ben Tre Pharmaceutical JSC Semi-Annual Data
FCF Margin %

STC:DBT vs ZTS, UTHR, VTRS: FCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ben Tre Pharmaceutical JSC's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ben Tre Pharmaceutical JSC FCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ben Tre Pharmaceutical JSC's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ben Tre Pharmaceutical JSC's FCF Margin % falls into.


STC:DBT
13GF Score
Ben Tre Pharmaceutical JSC STC:DBT
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ben Tre Pharmaceutical JSC FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ben Tre Pharmaceutical JSC's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Ben Tre Pharmaceutical JSC's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Ben Tre Pharmaceutical JSC (STC:DBT) has a FCF Margin % of 0.00% as of . 20. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ben Tre Pharmaceutical JSC and its competitors. According to the industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 955 companies in the Drug Manufacturers industry.
Is Ben Tre Pharmaceutical JSC's FCF Margin % too high?
Ben Tre Pharmaceutical JSC's current FCF Margin % is 0.00%. Based on the distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 955 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ben Tre Pharmaceutical JSC has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Ben Tre Pharmaceutical JSC's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ben Tre Pharmaceutical JSC ranks #999999 out of 955 companies for FCF Margin %. This places Ben Tre Pharmaceutical JSC in the lower half of its industry. The industry median FCF Margin % is 2.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ben Tre Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ben Tre Pharmaceutical JSC's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ben Tre Pharmaceutical JSC stock overvalued right now?
Ben Tre Pharmaceutical JSC (STC:DBT) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Ben Tre Pharmaceutical JSC's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ben Tre Pharmaceutical JSC (STC:DBT), the current FCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ben Tre Pharmaceutical JSC Business Description

Address No. 6A3, National Highway 60, Phu Tan Ward, Vinh Long Province, Ben Tre, VNM
Ben Tre Pharmaceutical JSC is based in Vietnam. The company is engaged in trading in pharmaceuticals, functional foods, vaccines, cosmetics, medical equipment, & medical machinery. It is also engaged in the Import and export of testing chemicals & biological products, Manufacturing medicines for human treatment, producing pharmaceuticals, chemicals, and medicinal herbs, and Leasing warehouses and premises.
13GF Score

Get the complete analysis for STC:DBT

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫12,000.00
Price